亿胜生物科技有限公司（股票代码：01061）公布将向股东寻求授权，于2026年5月26日召开股东周年大会，审议授予董事一般性购回股份授权，最高可达公司已发行股本的10%。根据公告，公司目前已发行股份总数约为567,006,000股，若获通过，购回规模最高可达56,700,600股。
公告显示，购回所需资金将来自公司可合法动用的资金来源，符合香港上市规则及开曼群岛相关法律规定。董事会表示，将在市况允许且有利于公司及股东整体利益时行使购回授权，以优化资本结构并提升股东回报。
公司提醒股东，相关决议将于2026年5月26日的股东周年大会上进行表决，届时需股东审议并表决通过方可正式生效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.